Factor XIII: Difference between revisions
CSV import |
No edit summary |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
== Factor_XIII == | == Factor_XIII == | ||
<gallery> | <gallery> | ||
File:Human_factor_XIII_1EVU.png|Human factor XIII | File:Human_factor_XIII_1EVU.png|Human factor XIII | ||
</gallery> | </gallery> | ||
Latest revision as of 21:02, 16 March 2025
Factor XIII (also known as Fibrin Stabilizing Factor) is a protein that plays a crucial role in the blood clotting process. It is a transglutaminase enzyme, which means it catalyzes the formation of covalent bonds between proteins. This is particularly important in the final stages of the clotting process, where Factor XIII cross-links fibrin, stabilizing the clot.
Structure[edit]
Factor XIII is a tetramer composed of two A subunits and two B subunits. The A subunits carry the catalytic site of the enzyme, while the B subunits act as carrier molecules, protecting the A subunits from premature activation.
Function[edit]
The primary function of Factor XIII is to stabilize the fibrin clot that forms at the site of a wound. It does this by cross-linking the fibrin strands, making the clot more resistant to degradation. This is a crucial step in the clotting process, as it ensures that the clot remains in place long enough for the wound to heal.
Deficiency[edit]
Factor XIII deficiency is a rare genetic disorder characterized by abnormal blood clotting. This can lead to a variety of symptoms, including abnormal bleeding, poor wound healing, and in severe cases, life-threatening bleeding disorders.
Treatment[edit]
Treatment for Factor XIII deficiency typically involves regular infusions of Factor XIII concentrate. This can help to prevent bleeding episodes and improve wound healing.



